Skip to search formSkip to main contentSkip to account menu

Ephrin Type-A Receptor 2, human

Known as: EC 2.7.1.112, Tyrosine-Protein Kinase Receptor ECK, Epithelial Cell Receptor Protein Tyrosine Kinase 
Ephrin type-A receptor 2 (976 aa, ~108 kDa) is encoded by the human EPHA2 gene. This protein plays a role in ephrin-A binding, cell-cell signaling… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Aging‐related osteoporosis (OP) is considered a serious public health concern. Approximately 30% of postmenopausal women suffer… 
2016
2016
ErbB2 signalling, which is amplified by EphA2 binding, is an important therapeutic target for breast cancer. Despite the… 
Highly Cited
2015
Highly Cited
2015
Tyrosine kinase inhibitors (TKIs) have become an important therapeutic option for treating several forms of cancer. Gefitinib, an… 
2014
2014
Neurological disorders are associated with an increase in the permeability of human brain microvascular endothelial cells (HBMEC… 
2013
2013
ABSTRACT Receptor tyrosine kinases (RTKs) exist in equilibrium between tyrosyl-phosphorylated and dephosphorylated states… 
2008
2008
The EphA2 receptor tyrosine kinase is an attractive therapeutic target that is commonly overexpressed on solid tumors, with the… 
2006
2006
Transcription factor p53 regulates its target genes through binding to DNA consensus sequence and activating the promoters of its… 
2006
2006
The EphA2 tyrosine kinase receptor is frequently overexpressed in ovarian cancer and this feature is predictive of poor clinical… 
2006
2006
Purpose: The EphA2 receptor tyrosine kinase is believed to play a role in tumor growth and metastasis.The clinical significance… 
2005
2005
9583 Background: EphA2 is a receptor tyrosine kinase for ephrin A-1 that has been implicated in a broad spectrum of functions…